210 related articles for article (PubMed ID: 19919882)
1. Circulating brain-reactive autoantibodies and behavioral deficits in the MRL model of CNS lupus.
Williams S; Sakic B; Hoffman SA
J Neuroimmunol; 2010 Jan; 218(1-2):73-82. PubMed ID: 19919882
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and early detection of CNS-SLE in MRL/lpr mice using peptide microarrays.
Williams S; Stafford P; Hoffman SA
BMC Immunol; 2014 Jun; 15():23. PubMed ID: 24908187
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.
Wen J; Xia Y; Stock A; Michaelson JS; Burkly LC; Gulinello M; Putterman C
J Autoimmun; 2013 Jun; 43():44-54. PubMed ID: 23578591
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin binding to brain in autoimmune mice.
Zameer A; Hoffman SA
J Neuroimmunol; 2001 Nov; 120(1-2):10-8. PubMed ID: 11694314
[TBL] [Abstract][Full Text] [Related]
5. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
Front Immunol; 2018; 9():2189. PubMed ID: 30319641
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal antibodies and brain damage in autoimmune MRL mice.
Stanojcic M; Loheswaran G; Xu L; Hoffman SA; Sakic B
Brain Behav Immun; 2010 Feb; 24(2):289-97. PubMed ID: 19853033
[TBL] [Abstract][Full Text] [Related]
8. Sex and autoantibody titers determine the development of neuropsychiatric manifestations in lupus-prone mice.
Gao HX; Sanders E; Tieng AT; Putterman C
J Neuroimmunol; 2010 Dec; 229(1-2):112-22. PubMed ID: 20800292
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
Stock AD; Wen J; Doerner J; Herlitz LC; Gulinello M; Putterman C
J Neuroinflammation; 2015 Nov; 12():205. PubMed ID: 26546449
[TBL] [Abstract][Full Text] [Related]
10. The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus.
Moore E; Huang MW; Jain S; Chalmers SA; Macian F; Putterman C
Front Immunol; 2020; 11():1476. PubMed ID: 32765512
[No Abstract] [Full Text] [Related]
11. Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).
Li Y; Eskelund AR; Zhou H; Budac DP; Sánchez C; Gulinello M
Int J Mol Sci; 2015 Jul; 16(7):15150-71. PubMed ID: 26151848
[TBL] [Abstract][Full Text] [Related]
12. Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice.
Nocito C; Lubinsky C; Hand M; Khan S; Patel T; Seliga A; Winfield M; Zuluaga-Ramirez V; Fernandes N; Shi X; Unterwald EM; Persidsky Y; Sriram U
Front Immunol; 2020; 11():573677. PubMed ID: 33042154
[TBL] [Abstract][Full Text] [Related]
13. Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus.
Ballok DA; Ma X; Denburg JA; Arsenault L; Sakic B
J Rheumatol; 2006 Nov; 33(11):2199-213. PubMed ID: 17086606
[TBL] [Abstract][Full Text] [Related]
14. Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus.
Sled JG; Spring S; van Eede M; Lerch JP; Ullal S; Sakic B
Arthritis Rheum; 2009 Jun; 60(6):1764-74. PubMed ID: 19479832
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal damage in mouse and human forms of systemic autoimmune disease.
Ballok DA; Woulfe J; Sur M; Cyr M; Sakic B
Hippocampus; 2004; 14(5):649-61. PubMed ID: 15301441
[TBL] [Abstract][Full Text] [Related]
16. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
[TBL] [Abstract][Full Text] [Related]
17. Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/
Huang MW; Stock AD; Mike EV; Herlitz L; Kolbeck R; Putterman C
Lupus; 2019 Nov; 28(13):1510-1523. PubMed ID: 31474191
[TBL] [Abstract][Full Text] [Related]
18. Identification of autoantigens specific for systemic lupus erythematosus with central nervous system involvement.
Iizuka N; Okamoto K; Matsushita R; Kimura M; Nagai K; Arito M; Kurokawa MS; Masuko K; Suematsu N; Hirohata S; Kato T
Lupus; 2010 May; 19(6):717-26. PubMed ID: 20026524
[TBL] [Abstract][Full Text] [Related]
19. Behavioral heterogeneity in an animal model of neuropsychiatric lupus.
Sakic B; Hanna SE; Millward JM
Biol Psychiatry; 2005 Mar; 57(6):679-87. PubMed ID: 15780857
[TBL] [Abstract][Full Text] [Related]
20. A Novel Microglia-Specific Transcriptional Signature Correlates With Behavioral Deficits in Neuropsychiatric Lupus.
Makinde HM; Winter DR; Procissi D; Mike EV; Stock AD; Kando MJ; Gadhvi GT; Droho S; Bloomfield CL; Dominguez ST; Mayr MG; Lavine JA; Putterman C; Cuda CM
Front Immunol; 2020; 11():230. PubMed ID: 32174913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
